how to start semaglutide Administer Your Own Injections at Home Everything You Need to Know

J MOL CELL CARDIOL

Key tips for underwriting applicants with GLP1 use Immediately look for: Evidence of the underlying diagnosis (as seen in medical claims, EHR, APS) Whether the GLP-1 is FDA-approved or off-label for that condition Signs of medication adherence (12 months, regular fills) Get cautious when: A GLP1 appears without any supporting clinical context Fills are intermittent or recently initiated Theres no alignment between the medication and expected companion therapies (e.g., no CPAP with sleep apnea) Be confident when: The diagnosis is clear The drug is first line and clinically appropriate Use has been stable long enough to confer benefit Kyle Schimek, PharmD Kyle Schimek is a board-certified pharmacist and Clinical Services Manager at Milliman IntelliScript

Possible risks if self-used incorrectly include mineral imbalance (copperzinc), skin irritation or hypersensitivity, and incorrect dosing with injectables

Because energy expenditure is increased within fat cells, the rate of cellular metabolism within these fat cells go up

Furthermore, ghrelin levels were found to be significantly lowered in individuals with autoimmune gastritis who exhibited delayed gastric emptying and impaired autonomic function